Abbott Laboratories (ABT) Plans $20B Bond Sale to Fund Exact Sci

Abbott Laboratories (ABT) plans to issue nearly $20 billion in bonds to finance its $21 billion acquisition of Exact Sciences (EXAS). The bond offering will have maturities ranging from three to 40 years. This strategic move follows the approval of the acquisition by Exact Sciences shareholders and aims to support Abbott’s diversified healthcare operations globally while maintaining a strong financial position.